Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HZ mRNA vaccine in adults aged 40 and older
NCT07400003Phase 2Recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jan 2026
- Primary completion
- May 2026
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lyophilized herpes zoster mRNA vaccine in herpes zoster (HZ), sponsored by Sinovac Biotech Ltd.. Started Jan 2026; status: recruiting.
02
Drugs
lyophilized herpes zoster mRNA vaccine
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT07400003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400003.